Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington’s diseaseAlba Di Pardo, Vittorio Maglione|Scientific Reports|2017Cited by 78
Sphingolipid Metabolism: A New Therapeutic Opportunity for Brain Degenerative DisordersAlba Di Pardo, Vittorio Maglione|Frontiers in Neuroscience|2018Cited by 77
The longevity-associated variant of BPIFB4 improves a CXCR4-mediated striatum–microglia crosstalk preventing disease progression in a mouse model of Huntington’s diseaseAlba Di Pardo, Annibale Alessandro Puca|Cell Death and Disease|2020Cited by 27